| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/14/1998 | US5780585 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form |
| 07/14/1998 | US5780469 Synergistic fungicides |
| 07/14/1998 | US5780449 Oligonucelotides; nucleotide sequences |
| 07/14/1998 | US5780448 Administering expression vector |
| 07/14/1998 | US5780447 Recombinant adeno-associated viral vectors |
| 07/14/1998 | US5780300 Contacting human progenitor cells with agonist of notch function to inhibit differentiation of cells and exposing cells to conditions for proliferation |
| 07/14/1998 | US5780298 DNA encoding the sn-RNP-A antigen and fragments thereof |
| 07/14/1998 | US5780292 Production of phytate degrading enzymes in trichoderma |
| 07/14/1998 | US5780291 Wnt-x growth factor polypeptide, DNA encoding same, and Wnt-x antibody |
| 07/14/1998 | US5780289 Coccidiosis poultry vaccine DNA encoding an elmeria 20K antigen |
| 07/14/1998 | US5780287 Photoactivated antiviral and antitumor compositions |
| 07/14/1998 | US5780286 Arginase II |
| 07/14/1998 | US5780285 Subtilisin variants capable of cleaving substrates containing dibasic residues |
| 07/14/1998 | US5780284 Ceramide glucosyltransferase |
| 07/14/1998 | US5780280 Culturing a cell having an epstein barr nuclear antigen gene and an adeno-associated virus transducing vector; introducing into the cell an adeno-associated virus cap gene and rep gene; genetic engineering |
| 07/14/1998 | US5780279 Method of selection of proteolytic cleavage sites by directed evolution and phagemid display |
| 07/14/1998 | US5780278 Nucleic acid encoding ?induced by contact with epithelium? (ice) protein of helicobacter pylori; diagnosis of gastrointestinal disorders |
| 07/14/1998 | US5780273 Insertion elements and amplifiable nucleic acids |
| 07/14/1998 | US5780272 Intron-mediated recombinant techniques and reagents |
| 07/14/1998 | US5780271 PCR assays for phytophthora species |
| 07/14/1998 | US5780270 Site-specific mutagenesis and mutant selection utilizing antibiotic-resistant markers encoding gene products having altered substrate specificity |
| 07/14/1998 | US5780269 Hybrid molecules |
| 07/14/1998 | US5780268 Polynucleotide; genetic engineering; medical diagnosis |
| 07/14/1998 | US5780266 Feline infectious peritonitis virus diagnostic tools |
| 07/14/1998 | US5780265 Kunitz type plasma kallikrein inhibitors |
| 07/14/1998 | US5780263 Human CCN-like growth factor |
| 07/14/1998 | US5780262 Max-interacting proteins and related molecules and methods |
| 07/14/1998 | US5780261 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
| 07/14/1998 | US5780245 Polypeptides having a serotonin receptor activity, nucleic acids coding for these polypeptides and uses |
| 07/14/1998 | US5780236 Method for identifying mutants and molecules |
| 07/14/1998 | US5780234 Nucleic acid mediated electron transfer |
| 07/14/1998 | US5780233 Artificial mismatch hybridization |
| 07/14/1998 | US5780230 Compositions and methods for human sperm activation and quantitative assessment of human sperm genome replication |
| 07/14/1998 | US5780229 Analyzing alloantigen phenotypes |
| 07/14/1998 | US5780228 High affinity nucleic acid ligands to lectins |
| 07/14/1998 | US5780225 Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| 07/14/1998 | US5780224 Target and background capture methods and apparatus for affinity assays |
| 07/14/1998 | US5780222 Method of PCR testing of pooled blood samples |
| 07/14/1998 | US5780053 Cationic phospholipids for transfection |
| 07/14/1998 | US5780040 Helicobacter pylori nickel binding protein |
| 07/14/1998 | US5780033 Use of autoantibodies for tumor therapy and prophylaxis |
| 07/14/1998 | US5780032 Method of using monoclonal antibodies to cytokeratin fragments |
| 07/14/1998 | US5780030 Passive vaccine against Lyme disease |
| 07/14/1998 | US5780025 Compositions and methods for the synthesis and assay of enkephalinase |
| 07/14/1998 | US5780009 Milk production |
| 07/14/1998 | US5779977 Nucleic acid amplification reaction apparatus and method |
| 07/14/1998 | CA2137728C Enzymatic removal of non-target nucleic acid from biological samples |
| 07/14/1998 | CA1339954C Dogs - and horse - interferones |
| 07/14/1998 | CA1339952C Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto |
| 07/10/1998 | CA2226695A1 H2-m modified transgenic animals |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/09/1998 | WO1998029744A2 Method to classify gene products |
| 07/09/1998 | WO1998029736A1 Multiplexed molecular analysis apparatus and method |
| 07/09/1998 | WO1998029570A1 A METHOD OF PRODUCING A TEMPORALLY SPACED SUBTRACTED (TSS) cDNA LIBRARY AND USES THEREOF |
| 07/09/1998 | WO1998029566A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029559A1 Process for preparing purified dimer of bone-derived factor |
| 07/09/1998 | WO1998029557A1 Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them |
| 07/09/1998 | WO1998029556A1 Recombinant adenoviral vector expressing antigens associated with colorectal tumors |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029554A1 Methods of conferring ppo-inhibiting herbicide resistance to plants by gene manipulation |
| 07/09/1998 | WO1998029553A1 A novel guanosine monophosphate reductase |
| 07/09/1998 | WO1998029552A1 Novel serine-threonine kinase gene |
| 07/09/1998 | WO1998029551A1 THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
| 07/09/1998 | WO1998029550A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis |
| 07/09/1998 | WO1998029549A1 The process for the expression and production of the recombinant growth factor protein (begf) derived from bean 58058 virus (bev) |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029547A1 Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof |
| 07/09/1998 | WO1998029546A1 Human rhombotin-like protein |
| 07/09/1998 | WO1998029545A1 NOVEL SEQUENCES OF p56 PROTEINS WHICH AFFECT K-ATP CHANNELS |
| 07/09/1998 | WO1998029544A1 Novel peptide, novel dna, and novel antibody |
| 07/09/1998 | WO1998029543A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 07/09/1998 | WO1998029542A1 Floral organ-specific genes and promoter sequences thereof |
| 07/09/1998 | WO1998029541A1 A process of making a compound by forming a polymer from a template drug |
| 07/09/1998 | WO1998029540A2 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM) |
| 07/09/1998 | WO1998029539A2 Partial sequences of purine biosynthesis genes from ashbya gossypii and their use in the microbial riboflavin synthesis |
| 07/09/1998 | WO1998029538A2 Gene for adenylate cyclase and its use |
| 07/09/1998 | WO1998029537A2 Method for protecting plants |
| 07/09/1998 | WO1998029536A2 Reversibly inactive synthetic beta-galactosidase |
| 07/09/1998 | WO1998029533A1 Vectors and methods for the mutagenesis of mammalian genes |
| 07/09/1998 | WO1998029532A1 A method of oocyte enucleation and production of reconstituted embryos |
| 07/09/1998 | WO1998029453A1 Cell membrane-directed drugs |
| 07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029444A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 07/09/1998 | WO1998029441A1 Human galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029440A1 Mouse galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029439A1 Galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029438A2 Cortistatin polypeptides |
| 07/09/1998 | WO1998029433A2 Method for solubilization and naturation of somatotropins |
| 07/09/1998 | WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | WO1998029431A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 07/09/1998 | WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | WO1998029138A2 Compositions and methods for tumour therapy |
| 07/09/1998 | WO1998029124A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 07/09/1998 | WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/09/1998 | WO1998028991A2 Cloudy fruit juices and methods for making same |
| 07/09/1998 | WO1998028971A2 Transgenic animals for in vivo visualization of beta-amyloid toxicity |
| 07/09/1998 | WO1998022597A3 Cloning and characterization of napsin, an aspartic protease |
| 07/09/1998 | WO1998022574A3 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |